Under the proposed legislation, most physically able participants in the Iowa Health and Wellness Plan would be required to ...

Cigna CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is most impactful in the drug discovery marketplace: Drug discovery companies ...

Currently, there are six FDA approved weight loss medications. They include three GLP-1 receptor agonists -- liraglutide ...

Billions of dollars in annual revenue and the health of millions of patients are at stake in a drug industry battle over who ...

Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space. BioSpace takes a look at the ...

JM Financial is bullish on Mounjaro's success in India, citing its price advantage, higher efficiency and the country's large ...

Investing in stocks remains one of the best ways to accumulate capital over long periods. Companies that can last -- and ...

The Hyderabad center is expected to be operational by mid-2025 and will be Lilly’s second capability center in India after ...

GLP-1 receptor agonists, originally introduced in 2006, have undergone significant advancements over the years. David Ricks, ...

With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for ...